DEUTSCHE BANK AG\ - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$2,106,358
+67.1%
692,881
+80.8%
0.00%0.0%
Q2 2023$1,260,698
+88.9%
383,191
+82.6%
0.00%
Q1 2023$667,488
-48.1%
209,902
+13.0%
0.00%
-100.0%
Q4 2022$1,285,625
+546.0%
185,784
+490.1%
0.00%
Q3 2022$199,000
+44.2%
31,486
-5.5%
0.00%
Q2 2022$138,000
-32.4%
33,327
-21.0%
0.00%
Q1 2022$204,000
-55.8%
42,178
-8.9%
0.00%
Q4 2021$462,000
-76.9%
46,301
-55.8%
0.00%
-100.0%
Q3 2021$2,002,000
+8.3%
104,740
+81.1%
0.00%0.0%
Q2 2021$1,849,000
+86.0%
57,830
+75.5%
0.00%0.0%
Q1 2021$994,000
-79.2%
32,948
-70.1%
0.00%
-66.7%
Q4 2020$4,774,000
-72.2%
110,360
-65.4%
0.00%
-75.0%
Q3 2020$17,195,000
-15.1%
318,732
-3.9%
0.01%
-20.0%
Q2 2020$20,250,000
+15.3%
331,737
-13.2%
0.02%
-6.2%
Q1 2020$17,563,000
-39.0%
382,122
+16.4%
0.02%
-15.8%
Q4 2019$28,792,000
+8.6%
328,152
+13.6%
0.02%
+5.6%
Q3 2019$26,521,000
-32.3%
288,867
-6.2%
0.02%
-21.7%
Q2 2019$39,157,000
-9.6%
307,861
+11.8%
0.02%
-11.5%
Q1 2019$43,310,000
+63.1%
275,298
+2.8%
0.03%
+36.8%
Q4 2018$26,562,000
-60.5%
267,788
-41.8%
0.02%
-5.0%
Q3 2018$67,214,000
-13.9%
460,389
-7.5%
0.02%
-9.1%
Q2 2018$78,093,000
+18.3%
497,593
+28.7%
0.02%
-29.0%
Q1 2018$65,989,000
+1.8%
386,483
+6.2%
0.03%
-26.2%
Q4 2017$64,820,000
+82.9%
363,972
+41.0%
0.04%
+75.0%
Q3 2017$35,448,000
+30.9%
258,103
+0.1%
0.02%
+26.3%
Q2 2017$27,083,000
-1.1%
257,829
-14.4%
0.02%
-5.0%
Q1 2017$27,386,000
+42.9%
301,313
-3.0%
0.02%
+33.3%
Q4 2016$19,171,000
-26.0%
310,756
-18.7%
0.02%
-16.7%
Q3 2016$25,896,000
+36.0%
382,110
-13.1%
0.02%
+38.5%
Q2 2016$19,035,000
+21.3%
439,780
+19.1%
0.01%
+8.3%
Q1 2016$15,688,000
-43.1%
369,195
-14.1%
0.01%
-36.8%
Q4 2015$27,590,000
-13.4%
429,645
+15.4%
0.02%
-24.0%
Q3 2015$31,847,000
-63.4%
372,316
-27.9%
0.02%
-54.5%
Q2 2015$86,935,000
+457.9%
516,341
+300.1%
0.06%
+450.0%
Q1 2015$15,583,000
+16.7%
129,055
-11.4%
0.01%
+25.0%
Q4 2014$13,357,000
+154.8%
145,641
-0.4%
0.01%
+166.7%
Q3 2014$5,243,000
+28.7%
146,170
+38.4%
0.00%0.0%
Q2 2014$4,073,000
+62.9%
105,633
-4.0%
0.00%
+50.0%
Q1 2014$2,500,000
+646.3%
110,023
+588.1%
0.00%
Q4 2013$335,000
-64.4%
15,990
-54.3%
0.00%
-100.0%
Q3 2013$942,00034,9580.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders